Trinity Biotech PLC Company Profile (NASDAQ:TRIB)

About Trinity Biotech PLC (NASDAQ:TRIB)

Trinity Biotech PLC logoTrinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic & Testing Substances Manufacturers
  • Sub-Industry: N/A
  • Symbol: NASDAQ:TRIB
  • CUSIP: N/A
  • Web: www.trinitybiotech.com
Capitalization:
  • Market Cap: $132.83 million
  • Outstanding Shares: 21,847,000
Average Prices:
  • 50 Day Moving Avg: $5.85
  • 200 Day Moving Avg: $5.94
  • 52 Week Range: $5.20 - $13.68
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 18.42
  • P/E Growth: 1.63
Sales & Book Value:
  • Annual Revenue: $98.79 million
  • Price / Sales: 1.34
  • Book Value: $4.89 per share
  • Price / Book: 1.24
Profitability:
  • EBIDTA: $7.39 million
  • Net Margins: -100.45%
  • Return on Equity: 5.19%
  • Return on Assets: 2.60%
Debt:
  • Debt-to-Equity Ratio: 0.87%
  • Current Ratio: 5.98%
  • Quick Ratio: 4.44%
Misc:
  • Average Volume: 48,832 shs.
  • Beta: 1.3
  • Short Ratio: 11.75
 
Frequently Asked Questions for Trinity Biotech PLC (NASDAQ:TRIB)

What is Trinity Biotech PLC's stock symbol?

Trinity Biotech PLC trades on the NASDAQ under the ticker symbol "TRIB."

How were Trinity Biotech PLC's earnings last quarter?

Trinity Biotech PLC (NASDAQ:TRIB) released its earnings results on Thursday, July, 20th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by $0.03. The business had revenue of $25.45 million for the quarter, compared to analysts' expectations of $24.83 million. Trinity Biotech PLC had a positive return on equity of 5.19% and a negative net margin of 100.45%. View Trinity Biotech PLC's Earnings History.

Who are some of Trinity Biotech PLC's key competitors?

Who are Trinity Biotech PLC's key executives?

Trinity Biotech PLC's management team includes the folowing people:

  • Ronan O'Caoimh, Executive Chairman of the Board
  • Kevin Tansley, Chief Financial Officer, Secretary
  • Rory Nealon, Chief Operating Officer, Executive Director
  • Eric Brouwer Ph.D., Chief Scientific Officer, and Vice President Cardiac
  • James Walsh Ph.D., Executive Director
  • Clinton H. Severson, Non-Executive Director
  • Denis R. Burger Ph.D., Senior Non-Executive Independent Director
  • Peter Coyne, Non-Executive Independent Director
  • James D. Merselis, Non-Executive Independent Director

Who owns Trinity Biotech PLC stock?

Trinity Biotech PLC's stock is owned by a number of of retail and institutional investors. Top institutional investors include US Bancorp DE (0.52%). View Institutional Ownership Trends for Trinity Biotech PLC.

Who sold Trinity Biotech PLC stock? Who is selling Trinity Biotech PLC stock?

Trinity Biotech PLC's stock was sold by a variety of institutional investors in the last quarter, including US Bancorp DE. View Insider Buying and Selling for Trinity Biotech PLC.

How do I buy Trinity Biotech PLC stock?

Shares of Trinity Biotech PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Trinity Biotech PLC's stock price today?

One share of Trinity Biotech PLC stock can currently be purchased for approximately $6.08.


MarketBeat Community Rating for Trinity Biotech PLC (NASDAQ TRIB)
Community Ranking:  2.2 out of 5 ( )
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  78 (Vote Underperform)
Total Votes:  137
MarketBeat's community ratings are surveys of what our community members think about Trinity Biotech PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Trinity Biotech PLC (NASDAQ:TRIB) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Trinity Biotech PLC (NASDAQ:TRIB)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/5/2016StephensDowngradeOverweight -> Equal WeightN/AView Rating Details
4/21/2016Roth CapitalReiterated RatingBuyN/AView Rating Details
10/23/2015Craig HallumDowngradeBuy -> Hold$24.00 -> $14.00N/AView Rating Details
9/3/2015Raymond James Financial, Inc.Initiated CoverageOutperform$20.00N/AView Rating Details
(Data available from 7/24/2015 forward)

Earnings

Earnings History for Trinity Biotech PLC (NASDAQ:TRIB)
Earnings by Quarter for Trinity Biotech PLC (NASDAQ:TRIB)
Earnings History by Quarter for Trinity Biotech PLC (NASDAQ TRIB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/20/20176/30/2017$0.06$0.03$24.83 million$25.45 millionViewN/AView Earnings Details
4/27/20173/31/2017$0.03$0.01$24.24 million$23.54 millionViewN/AView Earnings Details
10/25/2016Q3$0.07$0.07$26.50 million$26.10 millionViewListenView Earnings Details
7/21/2016Q2$0.06$0.09$24.30 million$26.30 millionViewListenView Earnings Details
4/19/2016Q1$0.08$0.06$24.34 million$23.52 millionViewListenView Earnings Details
3/3/2016Q4$0.09$0.29$251.00 million$271.20 millionViewN/AView Earnings Details
10/22/2015Q3$0.09$0.10$25.40 million$27.20 millionViewListenView Earnings Details
7/28/2015Q2$0.14$0.07$26.09 million$24.26 millionViewListenView Earnings Details
4/30/2015Q115$0.17$0.17$25.93 million$25.20 millionViewN/AView Earnings Details
3/3/2015Q414$0.18$0.18$27.30 million$26.70 millionViewN/AView Earnings Details
10/23/2014Q114$0.20$0.19$27.30 million$27.20 millionViewListenView Earnings Details
7/29/2014Q413$0.20$0.18$27.00 million$26.00 millionViewN/AView Earnings Details
4/29/2014$0.19$0.18$25.48 million$25.03 millionViewN/AView Earnings Details
3/4/2014Q4$0.21$0.20ViewN/AView Earnings Details
10/17/2013Q313$0.21$0.21$24.68 million$24.10 millionViewN/AView Earnings Details
7/30/2013Q2 2013$0.20$0.21$22.03 million$21.30 millionViewN/AView Earnings Details
3/5/2013Q4 2012$0.21$0.20$21.84 million$20.80 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Trinity Biotech PLC (NASDAQ:TRIB)
2017 EPS Consensus Estimate: $0.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.04$0.04$0.04
Q2 20171$0.06$0.06$0.06
Q3 20171$0.08$0.08$0.08
Q4 20171$0.08$0.08$0.08
(Data provided by Zacks Investment Research)

Dividends

Dividend History by Quarter for Trinity Biotech PLC (NASDAQ TRIB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/23/2014annual$0.223.72%6/6/20146/10/20147/1/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Trinity Biotech PLC (NASDAQ:TRIB)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Trinity Biotech PLC (NASDAQ:TRIB)
Latest Headlines for Trinity Biotech PLC (NASDAQ:TRIB)
Source:
DateHeadline
americanbankingnews.com logoTrinity Biotech PLC (TRIB) Issues Quarterly Earnings Results
www.americanbankingnews.com - July 21 at 11:05 AM
baystreet.ca logoInvestor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call
www.baystreet.ca - July 21 at 8:01 AM
baystreet.ca logoInvestor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call
www.baystreet.ca - July 21 at 8:01 AM
finance.yahoo.com logoEdited Transcript of TRIB earnings conference call or presentation 20-Jul-17 3:00pm GMT
finance.yahoo.com - July 21 at 8:01 AM
finance.yahoo.com logoEdited Transcript of TRIB earnings conference call or presentation 20-Jul-17 3:00pm GMT
finance.yahoo.com - July 21 at 8:01 AM
americanbankingnews.com logoHead-To-Head Survey: Trinity Biotech PLC (TRIB) & DBV Technologies (DBVT)
www.americanbankingnews.com - July 20 at 9:16 AM
americanbankingnews.com logoTrinity Biotech PLC (NASDAQ:TRIB) vs. DBV Technologies (DBVT) Head-To-Head Survey
www.americanbankingnews.com - July 20 at 9:15 AM
finance.yahoo.com logoTrinity Biotech Announces Results for Q2, 2017
finance.yahoo.com - July 20 at 8:51 AM
americanbankingnews.com logoContrasting Trinity Biotech PLC (TRIB) & DBV Technologies (DBVT)
www.americanbankingnews.com - July 18 at 12:27 AM
americanbankingnews.com logoTrinity Biotech PLC (TRIB) Set to Announce Earnings on Thursday
www.americanbankingnews.com - July 13 at 10:08 PM
finance.yahoo.com logoTrinity Biotech plc to Announce Second Quarter Fiscal Year 2017 Financial Results
finance.yahoo.com - July 4 at 8:10 AM
feeds.benzinga.com logoTrinity Biotech plc to Announce Second Quarter Fiscal Year 2017 Financial Results
feeds.benzinga.com - July 3 at 8:29 AM
americanbankingnews.com logoTrinity Biotech PLC (TRIB) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - July 2 at 4:58 PM
americanbankingnews.com logoComparing DBV Technologies (DBVT) and Trinity Biotech PLC (TRIB)
www.americanbankingnews.com - June 30 at 12:24 AM
americanbankingnews.com logoReviewing DBV Technologies (DBVT) & Trinity Biotech PLC (TRIB)
www.americanbankingnews.com - June 28 at 6:28 PM
americanbankingnews.com logoHead-To-Head Contrast: DBV Technologies (DBVT) & Trinity Biotech PLC (TRIB)
www.americanbankingnews.com - June 26 at 12:10 AM
americanbankingnews.com logoMeridian Bioscience (VIVO) versus Trinity Biotech plc (TRIB) Head-To-Head Comparison
www.americanbankingnews.com - June 9 at 8:57 AM
americanbankingnews.com logoTrinity Biotech plc (TRIB) Downgraded by ValuEngine to Sell
www.americanbankingnews.com - June 2 at 11:06 PM
finance.yahoo.com logoHarwood Feffer LLP Announces Investigation of Trinity Biotech plc
finance.yahoo.com - May 22 at 7:18 PM
americanbankingnews.com logoTrinity Biotech plc (TRIB) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - May 17 at 8:58 AM
americanbankingnews.com logoTrinity Biotech plc (TRIB) Cut to "Sell" at Zacks Investment Research
www.americanbankingnews.com - May 11 at 11:56 AM
finance.yahoo.com logoTrinity Biotech Plc :TRIB-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017
finance.yahoo.com - May 3 at 10:12 AM
finance.yahoo.com logoTrinity Biotech Plc :TRIB-US: Earnings Analysis: Q4, 2016 By the Numbers : May 1, 2017
finance.yahoo.com - May 1 at 7:26 PM
finance.yahoo.com logoEdited Transcript of TRIB earnings conference call or presentation 27-Apr-17 3:00pm GMT
finance.yahoo.com - April 28 at 11:07 PM
americanbankingnews.com logoTrinity Biotech plc (TRIB) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS
www.americanbankingnews.com - April 28 at 7:38 PM
americanbankingnews.com logoTrinity Biotech plc (TRIB) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS
www.americanbankingnews.com - April 28 at 4:50 PM
americanbankingnews.com logoSomewhat Negative News Coverage Extremely Likely to Impact Trinity Biotech plc (TRIB) Stock Price
www.americanbankingnews.com - April 28 at 1:17 PM
finance.yahoo.com logoInvestor Network: Trinity Biotech Plc Sponsored ADR Class A to Host Earnings Call
finance.yahoo.com - April 27 at 9:54 PM
finance.yahoo.com logoTrinity Biotech Announces Results for Q1, 2017
finance.yahoo.com - April 27 at 9:22 AM
streetinsider.com logoForm F-3/A TRINITY BIOTECH PLC
www.streetinsider.com - April 26 at 4:46 PM
americanbankingnews.com logoTrinity Biotech plc (TRIB) Getting Positive News Coverage, AlphaOne Reports
www.americanbankingnews.com - April 19 at 8:23 AM
feeds.benzinga.com logoTrinity Biotech plc to Announce First Quarter Fiscal Year 2017 Financial Results
feeds.benzinga.com - April 18 at 7:40 AM
americanbankingnews.com logoTrinity Biotech plc (TRIB) Getting Favorable Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 15 at 12:57 PM
americanbankingnews.com logoTrinity Biotech plc (TRIB) to Release Earnings on Monday
www.americanbankingnews.com - April 14 at 11:44 PM
finance.yahoo.com logoEdited Transcript of TRIB earnings conference call or presentation 14-Mar-17 3:00pm GMT
finance.yahoo.com - March 15 at 12:52 AM
reuters.com logoBRIEF-Trinity Biotech quarterly EPS $0.043
www.reuters.com - March 14 at 7:50 PM
finance.yahoo.com logoTrinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results
finance.yahoo.com - March 14 at 7:50 PM
biz.yahoo.com logoQ4 2016 Trinity Biotech PLC Earnings Release - Time Not Supplied
biz.yahoo.com - March 14 at 8:56 AM
americanbankingnews.com logoTrinity Biotech plc (TRIB) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - March 13 at 11:38 AM
prnewswire.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB) - PR Newswire (press release)
www.prnewswire.com - March 2 at 12:05 AM
finance.yahoo.com logoINVESTOR ALERT: Glancy Prongay & Murray Commences Investigation on Behalf of Trinity Biotech plc Investors
finance.yahoo.com - March 2 at 12:05 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB)
finance.yahoo.com - March 2 at 12:05 AM
finance.yahoo.com logoTrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2016 Financial Results
finance.yahoo.com - February 24 at 11:03 AM
feeds.benzinga.com logoTrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2016 Financial Results
feeds.benzinga.com - February 24 at 8:13 AM
marketwatch.com logoImmunoassay Markets: Global Analysis and Opportunity Evaluation 2016 - 2020
www.marketwatch.com - January 24 at 12:17 AM
finance.yahoo.com logoThe Top 200 IVD Companies In Europe
finance.yahoo.com - January 16 at 8:05 PM
businesswire.com logoBragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages ... - Business Wire (press release)
www.businesswire.com - January 7 at 6:07 AM
finance.yahoo.com logoBragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages Investors to Contact the Firm
finance.yahoo.com - January 6 at 6:15 AM
streetinsider.com logoForm 6-K TRINITY BIOTECH PLC For: Dec 01
www.streetinsider.com - December 19 at 8:54 AM

Social

Chart

Trinity Biotech PLC (TRIB) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff